| Name | Birtamimab |
|---|
| Description | Birtamimab (NEOD001) is an investigational monoclonal antibody that specifically and selectively target and clear the amyloid. Birtamimab can be used for the research of light chain amyloidosis[1]. |
|---|---|
| Related Catalog | |
| In Vitro | Birtamimab 可以中和循环中的可溶性淀粉样蛋白和沉积的不溶性淀粉样蛋白,从而促进淀粉样蛋白沉积物的吞噬清除[1]。 |
| References |
| No Any Chemical & Physical Properties |